SHIVA02 - Evaluation of the Efficacy of Targeted Therapy Based on Tumor Molecular Profiling in Patients With Advanced Cancer Using Each Patient as Its Own Control (SHIVA02)
Clinical trial NCT03084757 · COMPLETED
Trial details
- NCT number
- NCT03084757
- Sponsor
- Institut Curie
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-26
- Primary completion
- 2022-10-20
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.